Effectiveness of fresh frozen plasma as supplementary treatment in organophosphate poisoning

Medical Journal of Malaysia

Volumn 66, Issue 4, 2011, Pages 342-345

  Pazooki, S ^a   Solhi, H ^a   Khoddami Vishteh, H R ^a   Shadnia, S ^a   Bahram Beigi, M J ^a  

^a ARAK UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

FFP; Organophosphate poisoning; Pralidoxime

Indexed keywords

ATROPINE; FRESH FROZEN PLASMA; ORGANOPHOSPHATE; PRALIDOXIME;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; INTOXICATION; LENGTH OF STAY; MALE; MORTALITY; ORGANOPHOSPHATE POISONING; RANDOMIZED CONTROLLED TRIAL;

ADULT; ATROPINE; FEMALE; HUMANS; MALE; MIDDLE AGED; ORGANOPHOSPHORUS COMPOUNDS; PLASMA; PRALIDOXIME COMPOUNDS;

EID: 83755206559     PISSN: 03005283     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Jeyaratnam J. Acute pesticide poisoning: a major global health problem. World Health Stat Q 1990; 43: 139-44.
2. Moghadamnia AA, Abdollahi M. An epidemiological study of poisoning in northern Islamic Republic of Iran. East Mediterr Health J 2002; 8(1): 88-94.
3. Kanchan T, Menezes RG. Suicidal poisoning in Southern India: gender differences. J Forensic Leg Med 2008; 15(1): 7-14.
4. Rahimi R, Nikfar S, Abdollahi M. Increased morbidity and mortality in acute human organophosphate-poisoned patients treated by oximes: a meta-analysis of clinical trials. Hum Exp Toxicol 2006; 25(3): 157-62.
5. Kar N. Lethality of suicidal organophosphorus poisoning in an Indian population: exploring preventability. Ann Gen Psychiatry. 2006; 5: 17.
6. Loke WK, Sim MK, Go ML. O-Substituted derivatives of pralidoxime: muscarinic properties and protection against soman effects in rats. Eur J Pharmacol. 2002; 442(3): 279-87.
7. Eddleston M, Szinicz L, Eyer P, Buckley N. Oximes in acute organophosphorus pesticide poisoning: a systematic review of clinical trials. Q J Med 2002; 95(5): 275-83.
8. Sivagnanam S. Potential therapeutic agents in the management of organophosphorus poisoning. Crit Care 2002; 6(3): 260-61.
9. de Silva HJ, Wijewickrema R, Senanayake N. Does pralidoxime affect outcome of management in acute organophosphorus poisoning? Lancet 1992; 339(8802): 1136-8.
10. Sudakin DL, Mullins ME, Horowitz BZ, Abshier V, Letzig L. Intermediate syndrome after malathion ingestion despite continuous infusion of pralidoxime. J Toxicol Clin Toxicol 2000; 38(1): 4750.
11. Johnson MK, Jacobsen D, Meredith TJ, et al. Evaluation of antidotes for poisoning by organophosphorus pesticides. Emerg Med 2000; 12: 22-37.
12. Masson P, Froment MT, Bartels CF, Lockridge O. Importance of aspartate-70 in organophosphate inhibition, oxime re-activation and aging of human butyrylcholinesterase. Biochem J 1997; 325(Pt. 1): 53-61.
13. Peter JV, Moran JL, Graham P. Oxime therapy and outcomes in human organophosphate poisoning: an evaluation using meta-analytic techniques. Crit Care Med 2006; 34(2): 502-10.
14. Pawar KS, Bhoite RR, Pillay CP, Chavan SC, Malshikare DS, Garad SG. Continuous pralidoxime infusion versus repeated bolus injection to treat organophosphorus pesticide poisoning: a randomised controlled trial. Lancet 2006; 368(9553): 2136-41.
15. Peter JV, Moran JL, Sudarsanam TD, Graham P. High-dose pralidoxime for organophosphorus poisoning. Lancet 2007; 369(9571): 1425-6.
16. Peter JV, Moran JL, Pichamuthu K, Chacko B. Adjuncts and alternatives to oxime therapy in organophosphate poisoning--is there evidence of benefit in human poisoning? A review. Anaesth Intensive Care 2008; 36(3): 339-50.
17. Doctor BP, Saxena A. Bioscavengers for the protection of humans against organophosphate toxicity. Chem Biol Interact 2005; 157-158:167-71. (In press)
18. Güven M, Sungur M, Eser B. The effect of plasmapheresis on plasma cholinesterase levels in a patient with organophosphate poisoning. Hum Exp Toxicol 2004; 23(7): 365-8.
19. Güven M, Sungur M, Eser B, Sari I, Altuntaş F. The effects of fresh frozen plasma on cholinesterase levels and outcomes in patients with organophosphate poisoning. J Toxicol Clin Toxicol 2004; 42(5): 617-23.
20. Pichamuthu K, Jerobin J, Nair A, et al. Bioscavenger therapy for organophosphate poisoning -an open-labeled pilot randomized trial comparing fresh frozen plasma or albumin with saline in acute organophosphate poisoning in humans. Clin Toxicol (Phila) 2010; 48(8): 813-9. (In press)
21. Epstein HM, Jarzemsky D, Zuckerman L, Vagher P. Plasma cholinesterase activity in bank blood. Anesth Analg 1980; 59(3): 211-4.
22. Raveh L, Grunwald J, Marcus D, Papier Y, Cohen E, Ashani Y. Human butyrylcholinesterase as a general prophylactic antidote for nerve agent toxicity: in vitro and in vivo quantitative characterization. Biochem Pharmacol 1993; 45: 2465-74.
23. Broomfield CA, Maxwell DM, Solana RP, Castro CA, Finger AV, Lenz DE. Protection by butyrylcholinesterase against organophosphorus poisoning in nonhuman primates. J Pharmacol Exp Ther 1991; 259: 633-8.
24. Grunwald J, Marcus D, Papier Y, Raveh L, Pittel Z, Ashani Y. Large-scale purification and long-term stability of human butyrylcholinesterase: a potential bioscavenger drug. J Biochem Biophys Methods 1997; 34: 123-35.
25. Johnston Dg, Huff Wc. Stability Of Cholinesterase In Frozen Plasma. Clin Chem. 1965; 11: 729-32.